This document provides an overview of randomized controlled trials (RCTs). It discusses that RCTs are used to test interventions by randomly assigning participants to either an intervention or control group. The two groups are then compared on outcomes to see if any differences were caused by the intervention. It outlines the basic steps in RCTs, including developing a protocol, randomization methods, intervention/manipulation, follow-up, and outcome assessment. It also discusses types of RCT designs such as parallel group trials and crossover trials, as well as concepts like blinding and stratification.
Steps in conducting a RCT
1. Drawing up a protocol
2. Selecting Reference & Experimental population
3. Randomization
4. Manipulation or Intervention
5. Follow up
6. Assessment of outcome
1. Drawing up a protocol
Aims and objectives of the study
Questions to be answered
Criteria for the selection of study and control groups
Size of the sample & allocation of subjects in both groups
Treatment to be applied - when, where, how
Standardization of working procedures and
Schedules as well as responsibilities of persons involved in the trial up to the stage of evaluation of outcome of the study.
2. Selecting Reference and Experimental Populations
Reference or target population - Population to which the findings of the trial, if found successful, are expected to be applicable (Eg: drugs, vaccines, etc.)
Experimental or Study population
Derived from the Reference population
Has same characteristics as the Reference population
Actual population that participates in the experimental study
Must give informed consent - Should be qualified or eligible for the trial
3. Randomization
Heart of the control trial
Procedure:
Participants are allocated into study and control groups
Eliminates bias and allows comparability
By random allocation every individual gets an equal chance for being allocated in to either groups.
4. Manipulation/ Intervention
Having formed the study and control group, the next step is to intervene or manipulate the study (experimental) group by deliberate application or withdrawal or reduction of a suspected causal factor
Eg: Drug, Vaccine, Dietary component, a habit
5. Follow up
Implies examination of the experimental and control group subjects at defined intervals of time in a standard manner, with equal intensity, under the same given circumstances in the same time frame till final assessment of outcome.
Attrition:
Inevitable losses to follow up (death, migration, loss of interest)
6. Assessment
a. Positive results:
Reduced incidence or severity of disease
Reduced cost to health service
Appropriate outcome in the study
b. Negative results:
Increased severity or frequency of side effects
Complications
Deaths
BIAS:
Any systematic error in the determination of association and outcome.
Bias may arise from errors of assessment of outcome due to human element
Subjective bias
Observer bias
Evaluation bias
1. Subjective Bias:
Participants, subjectively feel better or report improvement if they knew they were receiving a new form of treatment. This is known as “Subject variation”.
2. Observer Bias:
Investigator measuring the outcome of a therapeutic trial may be influenced if he knows beforehand the particular procedure or therapy to which the patient has been subjected.
3. Evaluation Bias:
Investigator may subconsciously give a favorable report of the outcome of the trial.
Blinding:
1. Single Blind Trial: Participant
2. Double Blind: Partcipant + Investigator
3. Triple Blind: Participant + Investigator + Data Analyzer
Randomized control trial is so called because the patients who constitute the unit of study are allocated into ‘study group’ and ‘control group’ at random depending upon whether they receive or do not receive the intervention.
Steps in conducting a RCT
1. Drawing up a protocol
2. Selecting Reference & Experimental population
3. Randomization
4. Manipulation or Intervention
5. Follow up
6. Assessment of outcome
1. Drawing up a protocol
Aims and objectives of the study
Questions to be answered
Criteria for the selection of study and control groups
Size of the sample & allocation of subjects in both groups
Treatment to be applied - when, where, how
Standardization of working procedures and
Schedules as well as responsibilities of persons involved in the trial up to the stage of evaluation of outcome of the study.
2. Selecting Reference and Experimental Populations
Reference or target population - Population to which the findings of the trial, if found successful, are expected to be applicable (Eg: drugs, vaccines, etc.)
Experimental or Study population
Derived from the Reference population
Has same characteristics as the Reference population
Actual population that participates in the experimental study
Must give informed consent - Should be qualified or eligible for the trial
3. Randomization
Heart of the control trial
Procedure:
Participants are allocated into study and control groups
Eliminates bias and allows comparability
By random allocation every individual gets an equal chance for being allocated in to either groups.
4. Manipulation/ Intervention
Having formed the study and control group, the next step is to intervene or manipulate the study (experimental) group by deliberate application or withdrawal or reduction of a suspected causal factor
Eg: Drug, Vaccine, Dietary component, a habit
5. Follow up
Implies examination of the experimental and control group subjects at defined intervals of time in a standard manner, with equal intensity, under the same given circumstances in the same time frame till final assessment of outcome.
Attrition:
Inevitable losses to follow up (death, migration, loss of interest)
6. Assessment
a. Positive results:
Reduced incidence or severity of disease
Reduced cost to health service
Appropriate outcome in the study
b. Negative results:
Increased severity or frequency of side effects
Complications
Deaths
BIAS:
Any systematic error in the determination of association and outcome.
Bias may arise from errors of assessment of outcome due to human element
Subjective bias
Observer bias
Evaluation bias
1. Subjective Bias:
Participants, subjectively feel better or report improvement if they knew they were receiving a new form of treatment. This is known as “Subject variation”.
2. Observer Bias:
Investigator measuring the outcome of a therapeutic trial may be influenced if he knows beforehand the particular procedure or therapy to which the patient has been subjected.
3. Evaluation Bias:
Investigator may subconsciously give a favorable report of the outcome of the trial.
Blinding:
1. Single Blind Trial: Participant
2. Double Blind: Partcipant + Investigator
3. Triple Blind: Participant + Investigator + Data Analyzer
Randomized control trial is so called because the patients who constitute the unit of study are allocated into ‘study group’ and ‘control group’ at random depending upon whether they receive or do not receive the intervention.
Randomized Control Trials
Enigma of Blinding Unraveled
Introduction
RCT
Steps in a RCT
Allocation Concealment
Bias in RCT
Phases in RCT
Types of RCT
Study Designs of RCT
Blinding
Methods of Blinding in different trials
Assessment of Blinding
Un-blinding
Current Scenario of Blinding
CONSORT
Conclusion
References
The randomised controlled trial (RCT) .pptxPRITIBISANE
Randomized controlled trials (RCT) are prospective studies that measure the effectiveness of a new intervention or treatment.
Randomization reduces bias and provides a rigorous tool to examine cause-effect relationships between an intervention and outcome
RANDOMIZED CONTROL trials
an assessment method
questions validity and applicability of many preventive and therapeutic procedures
reference Park's Preventive and social medicine
Randomized Control Trials
Enigma of Blinding Unraveled
Introduction
RCT
Steps in a RCT
Allocation Concealment
Bias in RCT
Phases in RCT
Types of RCT
Study Designs of RCT
Blinding
Methods of Blinding in different trials
Assessment of Blinding
Un-blinding
Current Scenario of Blinding
CONSORT
Conclusion
References
The randomised controlled trial (RCT) .pptxPRITIBISANE
Randomized controlled trials (RCT) are prospective studies that measure the effectiveness of a new intervention or treatment.
Randomization reduces bias and provides a rigorous tool to examine cause-effect relationships between an intervention and outcome
RANDOMIZED CONTROL trials
an assessment method
questions validity and applicability of many preventive and therapeutic procedures
reference Park's Preventive and social medicine
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
2. INTRODUCTION
• Randomization as a basic principle of experimental design in
the 1920s was developed by RA fisher who presented
randomization as an essential ingredient of his approach to
the design and analysis of experiments, validating
significance tests predominantly in agricultural research
2
3. RCT
RANDOMIZED CONTROLLED TRIAL
An RCT is conducted to test whether an intervention or treatment
works.
The investigators will randomly allocate the participants either to
the intervention group (which will receive the therapy or preventive
action), or to control group (which will receive the usual or no
treatment).
The two groups are then compared on outcome of interest. Since
random assignment equalizes the groups on all other variables,
any differences in outcome between treatment and control were
actually caused by the treatment.
Study
sample
Interventio
n group
Control
group
Outcome
Outcome
Randomizatio
n
Follow up Analysis
4. BASIC STEPS IN RANDOMIZED
CONTROLLED TRIALS
1. Drawing up a protocol
2. Selecting reference and experimental populations
3. Randomization
4. Manipulation and intervention
5. Follow up
6. Assessment of outcome
4
5. 1.THE PROTOCOL
• Study is conducted under strict protocol
• Specifies aims and objectives of study; questions to be
answered; criteria for selection of study and control groups;
parties involved in trial; stage of evaluation of study
• Aims at preventing bias and to reduce sources of error in
study at times preliminary tests ie pilot studies are done –
to find feasibility of certain procedures or acceptability of
certain policies
• Should be agreed by all concerned before trial begins
5
6. 2. SELECTING REFERENCE AND
EXPERIMENTAL POPULATIONS
• Reference/ target population:
• Population to which findings of trial; if found successful, are expected to be
applicable
• Can be as broad as a mankind or geographically limited or limited to persons
in specific age, sex, occupational or social group
• Experimental population:
• Derived from reference population - randomly
• Population that participates in the study
• They should have same characteristics as reference group
• They should be informed, should be qualified and eligible
6
7. 3.RANDOMIZATION
• Randomization procedure by which participants are
allocated into groups called study and control
groups
• Attempt to eliminate bias and allow comparability
• Selection bias
• Every individual gets an equal chance of being
allocated into any of trial group
• Done only after participant has entered the study i.e,
given consent and is qualified
7
8. CRITERIA FOR RANDOMIZATION
• Unpredictability
• Each participant has the same chance of receiving any of the
interventions.
• Allocation is carried out using a chance mechanism so that
neither the participant nor the investigator will know in advance
which will be assigned.
• Balance
• Treatment groups are of a similar size & constitution, groups are
alike in all important aspects and only differ in the intervention
each group receives
• Simplicity
• Easy for investigator/staff to implement
8
10. 1.Simple randomization
Randomization based on a single sequence of random
assignments is known as simple randomization .
The most common and basic method of simple
randomization is flipping a coin
Advantage
Simple and easy to implement
10
11. 2.Stratified randomization
11
Stratification prior to randomization can be used to ensure that
the number of patients assigned to the experimental and control
arms are balanced with respect to important attributes
(stratification variables).
Examples of stratification variables are gender or disease stage.
The purposes of stratification are two-fold.
12. 3.Block randomization
the block randomization method is designed to randomize subjects into groups that
result in equal sample sizes.
This method is used to ensure a balance in sample size across groups over time.
Blocks are small and balanced with predetermined group assignments, which keeps the
numbers of subjects in each group similar at all times.
The block size is determined by the researcher and should be a multiple of the number
of groups (i.E., With two treatment groups, block size of either 4, 6, or 8).
Blocks are best used in smaller increments as researchers can more easily control
balance
Advantage
balance between the numbers of participants in each group is guaranteed during course
of randomization.
If the trial is terminated before enrolment is completed, balance will exist in terms of
number of participants randomized to each group.
Disadvantage
analysis of data is more complicated than simple randomization. Also with fixed blocks,
people involved in the trial may be able to predict the group assignment of participants
being randomized at the last in the block. Block randomization
12
14. 4.Unequal randomization
When two or more treatments under evaluation have
a cost difference it may be more economically
to randomize fewer patients to the expensive
treatment and more to the cheaper one.
The substantial cost savings can be achieved by
adopting a smaller randomization ratio such as a
of 2:1, with only a modest loss in statistical power.
When one arm of the treatment saves lives and the
other such as placebo/medical care only does not
much to save them in the oncology trials. The subject
survival time depends on which treatment they
14
15. 4. MANIPULATION &
5.INTERVENTION
• Manipulation
• This is to manipulate the study
• Done by application or withdrawal or reduction of
suspected causal factor
• Creates independent variable – whose effect is then
determined by measurement of final outcome ie
dependent variable
• FOLLOW-UP:
• Examination of experimental and control groups at defined
intervals of time
• Attrition may be seen
15
16. 6.ASSESSMENTOF
OUTCOME
ASSESSMENT: of outcome of trials
• Positive results: benefits of experimental measures
• Negative results: severity and frequency of side effects
and complications of any
Incidence of negative and positive results is compared
in both the groups – and differences if any are tested
statistically.
Bias may arise from error of assessment of outcome:
subject variation
observer bias
bias in evaluation
16
17. BLINDING
• SINGLE BLIND TRIALS:
• PARTICIPANT IS NOT AWARE WHETHER HE BELONGS
TO STUDY OR CONTROL GROUP
• DOUBLE BLIND TRIALS:
• NEITHER THE PARTICIPANT NOR THE DOCTOR IS
AWARE OF GROUP ALLOCATION OR THE TREATMENT
BEING RECEIVED
• TRIPLE BLIND TRIALS:
• PARTICIPANT, DOCTOR AND INVESTIGATOR ALL THREE
ARE BLIND
17
18. TYPES OF RCT DESIGN
1. PARALLEL GROUP TRIAL DESIGN
2. CROSS-OVER TRIAL DESIGN
3. FACTORIAL DESIGN
18
19. • 1. A PARALLEL Study is a type of clinical study where
treatment and controls are allocated to different
individuals.
• In this two groups of treatments, a and b, are
so that one group receives only a while another
group receives only b
19
20. • 2. CROSS-OVER TRIAL DESIGN
• In these types of studies each patient serves as his own control.
Each patient gets both treatments.
• Each patient receive first treatment then washout time is
provided then other treatment is provided to the same
• This ‘carry-over effect’ or the ‘spill-over effect’ of the first intervention
could result in error in the reading of the second intervention. Hence
enough time is allowed to pass, known as ‘wash-out period’ between
the two interventions.
20
21. • 3.FACTORIAL DESIGN
• Studies involving two or more factors while randomizing are
called factorial.
• Factorial design permits researchers to investigate the joint
effect of two or more factors on a dependent variable.
• Used when it is desired to study the influence of a number
factors on the treatments compared as well as their
interaction with different treatments factors on a dependent
variables l design
21